Lungpacer Medical
EXTON, PA · Healthcare, Health Care · 58 employees
Lungpacer Medical, Inc., is a privately held medical device company focused on improving respiratory and critical care medicine. Headquartered in Vancouver, Canada, and with US offices in Exton, Pennsylvania, Lungpacer Medical is dedicated to designing non-surgical, minimally invasive technologies to ventilate patients more safely and effectively.
Funding history
- Funding Round — $12.0M — Apr 2026
- Funding Round — $10.0M — Apr 2025
- Funding Round — $16.0M — Dec 2022
- Funding Round — $20.0M — Apr 2022
- Funding Round — $16.0M — Jan 2022
Recent signals
- Jun 01, 2026: Lungpacer Medical Appoints Steven Pfanstiel as Chief Financial Officer
- Apr 28, 2026: Raised $12.0M
- Apr 01, 2025: Raised $10.0M
- Dec 05, 2024: Launched Lungpacer Medical Launches AeroPace® System to Enhance Weaning from Mechanical Ventilation
- Dec 13, 2022: Raised $16.0M
- Apr 19, 2022: Raised $20.0M
- Jan 06, 2022: Raised $16.0M
- Jan 06, 2021: Raised $16.0M
See plans & pricing → Track Lungpacer Medical’s funding, hiring, and signals — with verified contacts — on Fundz.